Value Assessment: Investment Opportunities and Risk Warnings from Limit-Down Stocks (July 21) | Listed Company Watch

On July 21, China's A-share market staged a strong rebound after an initial dip, with all major indices closing sharply higher. The Shanghai Composite Index ended at 3,864.37 points, up 1.79%; the Shenzhen Component Index surged 4.81%, while the ChiNext Price Index jumped 7.05%. The STAR 50 Index also rose significantly. Total market turnover reached RMB 2.96 trillion, an increase of over RMB 250 billion from the previous trading day, highlighting notable inflows of incremental capital. The market exhibited extreme structural divergence: semiconductor and computing hardware stocks rallied across the board, with more than 3,100 stocks ending higher. However, over 2,300 stocks still declined, and a total of 27 stocks hit the daily trading limit down, underscoring concentrated liquidity risks among small-cap names.

Market funds underwent a significant rotation, with institutional capital pouring into high-momentum tech sectors such as semiconductor equipment, memory chips, and CPO-related computing infrastructure, triggering mass rallies in these segments. Conversely, capital continued to exit healthcare distribution, traditional cyclical sectors, and speculative small-cap stocks. Medical devices, metal manufacturing, engineering consulting, optical materials, and industrial electronics were among the worst-hit sectors. Numerous small- and mid-cap stocks were driven to their daily trading limits down due to sentiment-driven selling pressure, reflecting a concentrated release of downward momentum in speculative small caps.

1. Saili Medical (603716): Severely overvalued amid fading speculative hype, leading to profit-taking and a locked limit-down

The company primarily operates in smart healthcare supply chains and the distribution of in-vitro diagnostic reagents, focusing on hospital consumables logistics and healthcare IT services. Its share price had previously benefited from short-term speculation around medical consumables, driving a rapid rally. Over the past five trading days, it still posted a gain of 4.22%, delivering substantial short-term profits for investors. However, the company currently faces weak fundamentals, slowing revenue growth, and underwhelming channel expansion, lacking a clear medium- to long-term earnings realization story. Coupled with a broader valuation correction across the healthcare sector, profit-taking by investors holding elevated positions triggered a straight-line limit-down on July 21.

Risk WarningThe current share price is overvalued by 74.40% relative to JYan's fair valuation, indicating severe valuation bubbles and a complete decoupling from fundamental support. Short-term speculative capital has reaped substantial profits and shows strong willingness to sell. With no near-term catalysts for fundamental improvement, there remains significant room for valuation correction, and the risk of continued downside is pronounced. Investors are advised to avoid attempting to catch a falling knife.

2. Guizhou Wire Rope Co., Ltd. (600992): Concept-driven speculation has fizzled out; elevated valuation combined with persistent capital outflows triggered a trading limit down.

The company’s core business involves manufacturing metal products such as steel wire, wire rope, and steel strand, which are used in construction machinery, ports, mining, and other sectors. For an extended period, its stock price has been driven by recurring asset injection and restructuring rumors, deviating significantly from industry fundamentals. The recent rapid cooling of market speculation, coupled with weak cyclical conditions in traditional manufacturing, has led to sustained capital outflows. The stock has plunged 15.27% cumulatively over the past five days and hit another trading limit down on July 21.

Risk WarningThe share price is overvalued by 48.72% compared to JYan’s fair valuation, significantly higher than peers in the manufacturing sector. Restructuring expectations are gradually being disproven, and the company lacks a credible long-term growth narrative. Short-term capital flight is evident, and the stock remains under downward pressure from valuation correction. A wait-and-see stance is recommended.

1. Gansu Engineering Consulting Group Co., Ltd. (000779): Two consecutive trading limit downs reflect deep undervaluation; infrastructure stabilization policies provide long-term value support.

The company primarily engages in engineering consulting, water conservancy design, municipal planning, and project supervision, with deep integration into water infrastructure and urban renewal projects in Northwest China, positioning it as a core beneficiary of infrastructure stabilization policies. Dragged down by broad-based selloffs in thematic stocks, panic-driven sentiment triggered two consecutive trading limit downs, resulting in a cumulative 7.90% decline over the past five days. The current share price is substantially below intrinsic value—undervalued by 50.70% relative to JYan’s fair valuation—representing a classic case of sentiment-driven mispricing. The company holds ample water infrastructure project backlog, and ongoing disbursement of special-purpose local government bonds will continue to drive order growth, with no material negative fundamentals.

OpportunityTipThe share price is deeply undervalued by 50.70%. The consecutive trading limit downs were solely caused by market panic and liquidity-driven selling pressure typical of small-cap stocks. The company’s infrastructure business fundamentals remain solid, with rigid policy-backed support from regional water investment. Substantial valuation recovery potential exists over the medium to long term. Investors should monitor the implementation of infrastructure policies and announcements of new orders, awaiting opportunities to position once sentiment stabilizes.

2. Daoming Optics & Chemical Co., Ltd. (002632): Leading optical materials producer mispriced and undervalued; valuation recovery window emerging after consecutive trading limit downs.

A domestic leader in retroreflective materials and functional films, the company offers products including traffic safety films, lithium battery aluminum-plastic films, and optical films, with strategic exposure to both new energy and transportation infrastructure sectors. Recent market rotation and tightened liquidity for small-cap stocks triggered two consecutive trading limit downs. Despite this, the stock posted a modest 0.70% gain over the past five days, with stable fundamentals. Capacity expansion in lithium battery new materials continues, supporting expectations for earnings improvement. The current share price is undervalued by 47.20% relative to JYan’s fair valuation, reflecting a significant disconnect between market sentiment and the company’s true worth.

OpportunityTipThe stock is significantly undervalued by 47.20%. Its consecutive daily trading limits down are not driven by any fundamental negative catalysts but rather by liquidity-driven panic selling typical of small-cap stocks. The company’s dual businesses—lithium battery separator films and retroreflective materials—are steadily scaling up, supported by strong long-term industry demand and solid competitive moats as a market leader. Once short-term sentiment stabilizes, a valuation recovery rally is likely, making it suitable for tracking on dips.

3. Yidao Information (001314): Consumer electronics hardware stock hit consecutive daily trading limits down, but its low valuation presents potential for recovery.

The company primarily produces industrial tablet PCs, ruggedized smart hardware, and IoT terminal devices, serving sectors such as industrial automation, warehouse logistics, and commercial hardware. Recently, the broader consumer electronics sector underwent a collective correction, compounded by weak liquidity typical of newly listed stocks, leading to two consecutive daily trading limits down and a sharp 15.62% decline over the past five days. The company maintains stable overseas customer channels, and demand for industrial digitalization abroad continues to expand, providing a solid foundation for steady earnings growth. The current share price is undervalued by 31.18% relative to Jiaan’s fair value estimate, creating a strategic window for value-oriented positioning amid short-term panic selling.

OpportunityTipThe stock is undervalued by 31.18%. Its consecutive daily trading limits down stem from liquidity-driven panic among newly listed stocks and a short-term sector-wide pullback. The company operates in the industrially oriented IoT hardware segment, which enjoys sustained long-term growth prospects, and its overseas business offers significant expansion potential. Following sufficient release of short-term selling pressure, valuation recovery opportunities exist; investors should closely monitor overseas order trends and quarterly earnings developments.

On July 21, the market index rallied sharply on high volume, led by semiconductor and computing power-related sectors. However, amid a shift in capital allocation style, numerous small-cap stocks weakened significantly, with 27 individual stocks hitting the daily trading limit down. Pharmaceuticals, traditional cyclical sectors, and speculative small-cap names experienced notable capital outflows.

Among the day's two newly limit-down stocks, valuation bubbles were pronounced: Saile Healthcare was overvalued by 74.40%, and Guizhou Wire Rope by 48.72%. Both were purely driven by speculative themes without fundamental support, implying high correction risk and warranting avoidance. In contrast, three stocks experiencing consecutive daily trading limits down were victims of emotional overselling—their prices now significantly below intrinsic value, with no material fundamental negatives. These present medium- to long-term valuation recovery opportunities.

Near-term portfolio allocation should focus on three key themes: high-conviction tech leaders in semiconductor equipment, memory chips, and computing power hardware; infrastructure-focused water conservancy stocks that support economic stability; and undervalued new materials and industrial electronics names that have been emotionally oversold.

In terms of trading strategy, avoid small-cap stocks with severely inflated valuations driven solely by speculative narratives. Such names have not yet fully cleared their selling pressure and remain vulnerable to further adjustments.

For more in-depth analysis and exclusive insights on global markets, multinational corporations, and China’s economy, please visit

6403 Views